Health Trials

Antibody

2

Review clinical trials related to Antibody. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT

This trial is designed to investigate the safety, response rates and survival outcomes of patients with hepatocellular carcinoma by infusion of CTLA4, PD1 and PDL1 antibodies combination with chemodrug or/and bevacizumab through intra-tumor (IT).

Participants needed: 90
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Second Affiliated Hospital of Guangzhou Medical UniversityUpdated: Jul 1, 2024Locations: 1
Eligibility criteria

Cytohistological confirmation is required for diagnosis of cancer. [+8]

Patients participated in clinical trials of equipment or drugs (signed informed... [+8]

Read more
Status: Recruiting

COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research

A prospective, open-label and parallel non-randomized control trial and biomarker research study is intended to compare incidence of repeated COVID-19 infection, severe pneumonitis and mortality between lung cancer patients undergoing systemic antitumor therapies who get vaccinated with 1 booster dose(majorly against XBB) and those who refuse. Meanwhile, a biomarker research is designed to monitor serum level dynamics of specific antibodies against COVID-19,analyze its correlation with incidence of breakthrough infection and further explore optimal periods for vaccination.

Participants needed: 1,224
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Peking Union Medical College HospitalUpdated: Dec 13, 2023Locations: 1
Eligibility criteria

Patients who agree to participate in the trial and sign the informed consents. [+6]

Life expectance less than 3 months. [+4]

Read more